NCT03310892View on ClinicalTrials.gov

Tailored Messaging for CRC Screening

NACompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

October 9, 2017

Primary Completion Date

June 30, 2023

Study Completion Date

October 1, 2023

Conditions
Colorectal Cancer
Interventions
BEHAVIORAL

Generic message

Generic message

BEHAVIORAL

Tailored message

Tailored message

Trial Locations (1)

19104

University of Pennsylvania Health System, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT03310892 - Tailored Messaging for CRC Screening | Biotech Hunter | Biotech Hunter